Psoriasis Therapeutics and Marketing
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be …
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be … 
JDD Podcast Recap & Ask the Investigator on Hyperhidrosis Treatment Innovation
Hyperhidrosis represents a great clinical challenge: it can be debilitating for patients, and treatment options are few. In this edition of the JDD Podcast, Dr. Adam Friedman interviews Dr. Suneel Chilukuri, aninternationally recognized procedural dermatologist and the Director of Cosmetic Surgery at Refresh Derm … 
Have you received your September JDD issue yet? The Special Focus of this month's issue is Aesthetics. Below are the highlights for the September issue!
Highlights:
Topical EGF is a safe, noninvasive, and effective in A Randomized, Double-
Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical
Epidermal Growth Factor for the Treatment of Melasma.
The fourth in a ser … 
Each month, the JDD Dermatology Podcast features an in-depth interview with one of the investigators from the Journal of Drugs in Dermatology current issue. July’s podcast, hosted by Dr. Adam Friedman, features Dr. Beth McLellan, an assistant professor of Dermatology from the Albert Einstein College of Medicine and an expert in supportive oncodermatology – the treatment and prevention of cutan … 
Have you received your August issue of the JDD yet? This month's issue contains a special focus on Psoriasis, as August is Psoriasis Awareness Month! Below are the issue highlights and Editor Picks for the August issue of JDD!
In Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years, high levels of effi …